BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 11274621)

  • 1. The effectiveness of the varicella vaccine in clinical practice.
    Vázquez M; LaRussa PS; Gershon AA; Steinberg SP; Freudigman K; Shapiro ED
    N Engl J Med; 2001 Mar; 344(13):955-60. PubMed ID: 11274621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outbreak of varicella at a day-care center despite vaccination.
    Galil K; Lee B; Strine T; Carraher C; Baughman AL; Eaton M; Montero J; Seward J
    N Engl J Med; 2002 Dec; 347(24):1909-15. PubMed ID: 12477940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
    Hardy I; Gershon AA; Steinberg SP; LaRussa P
    N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness over time of varicella vaccine.
    Vázquez M; LaRussa PS; Gershon AA; Niccolai LM; Muehlenbein CE; Steinberg SP; Shapiro ED
    JAMA; 2004 Feb; 291(7):851-5. PubMed ID: 14970064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
    Gershon AA; Steinberg SP
    N Engl J Med; 1989 Apr; 320(14):892-7. PubMed ID: 2538749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of catch-up vaccination: experience from a varicella outbreak, Maine, 2002-2003.
    Marin M; Nguyen HQ; Keen J; Jumaan AO; Mellen PM; Hayes EB; Gensheimer KF; Gunderman-King J; Seward JF
    Pediatrics; 2005 Apr; 115(4):900-5. PubMed ID: 15805362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 2002-2003.
    Haddad MB; Hill MB; Pavia AT; Green CE; Jumaan AO; De AK; Rolfs RT
    Pediatrics; 2005 Jun; 115(6):1488-93. PubMed ID: 15930208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of laboratory methods for diagnosis of varicella.
    Leung J; Harpaz R; Baughman AL; Heath K; Loparev V; Vázquez M; Watson BM; Schmid DS
    Clin Infect Dis; 2010 Jul; 51(1):23-32. PubMed ID: 20504232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of varicella vaccine in China.
    Fu C; Wang M; Liang J; Xu J; Wang C; Bialek S
    Pediatr Infect Dis J; 2010 Aug; 29(8):690-3. PubMed ID: 20216242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An elementary school outbreak of varicella attributed to vaccine failure: policy implications.
    Lee BR; Feaver SL; Miller CA; Hedberg CW; Ehresmann KR
    J Infect Dis; 2004 Aug; 190(3):477-83. PubMed ID: 15243919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of varicella vaccination in children in Germany: a case-control study.
    Liese JG; Cohen C; Rack A; Pirzer K; Eber S; Blum M; Greenberg M; Streng A
    Pediatr Infect Dis J; 2013 Sep; 32(9):998-1004. PubMed ID: 23694831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine.
    Bernstein HH; Rothstein EP; Watson BM; Reisinger KS; Blatter MM; Wellman CO; Chartrand SA; Cho I; Ngai A; White CJ
    Pediatrics; 1993 Dec; 92(6):833-7. PubMed ID: 8233746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of vaccine-induced immunity to varicella over time.
    Chaves SS; Gargiullo P; Zhang JX; Civen R; Guris D; Mascola L; Seward JF
    N Engl J Med; 2007 Mar; 356(11):1121-9. PubMed ID: 17360990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study.
    Baxter R; Ray P; Tran TN; Black S; Shinefield HR; Coplan PM; Lewis E; Fireman B; Saddier P
    Pediatrics; 2013 May; 131(5):e1389-96. PubMed ID: 23545380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of varicella vaccines as postexposure prophylaxis.
    Brotons M; Campins M; Méndez L; Juste C; Rodrigo JA; Martínez X; Hermosilla E; Pinós L; Vaqué J
    Pediatr Infect Dis J; 2010 Jan; 29(1):10-3. PubMed ID: 19841607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.